{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:25:18Z","timestamp":1770071118383,"version":"3.49.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Aberrant interferon (IFN) signalling is strongly associated with rheumatic diseases, particularly rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Blood dendritic cell antigen 2 (BDCA-2) regulates IFN production in plasmacytoid dendritic cells (pDCs). While heparin inhibits IFN formation via triggering surface BDCA-2, its soluble form (solBDCA-2) antagonizes heparin and thereby drives excessive IFN formation. However, the role of solBDCA-2 in RA and SLE is unknown. This study aims to determine whether solBDCA-2 can serve as a biomarker for RA and\/or SLE and provide insights into its potential role in disease mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>solBDCA-2 and IFN-\u03b1 expression were analysed by ELISA in the serum of RA (n\u2009=\u200914) and SLE (n\u2009=\u200914) patients and compared with healthy controls (n\u2009=\u200915). To gain mechanistic insight of solBDCA-2 in RA and SLE, we studied the interaction of solBDCA-2 with nucleic acids, its role in enhancing type I IFN production in the plasmacytoid dendritic cell line CAL-1 and in human peripheral blood mononuclear cells (hPBMCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IFN-\u03b1 was upregulated in patient sera of both RA and SLE. In contrast, solBDCA-2 was exclusively upregulated in the serum of RA patients, but not in patients with SLE. solBDCA-2 interacted with phosphodiester CpG-oligodeoxynucleotides (ODN) 2006, a ligand of TLR9, and poly I:C, a ligand of TLR3, to form complexes that enhance type I IFN production in CAL-1 cells and hPBMCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings show that solBDCA-2 enhances type I interferon production by forming immunostimulatory complexes with DNA and RNA. Dysregulated solBDCA-2 expression might contribute to RA pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf537","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:23:58Z","timestamp":1760617438000},"source":"Crossref","is-referenced-by-count":0,"title":["Soluble BDCA-2 as a potential biomarker for rheumatoid arthritis and its role in enhancing IFN-\u03b1 production through nucleic acid binding"],"prefix":"10.1093","volume":"65","author":[{"given":"Lisa","family":"Mainieri","sequence":"first","affiliation":[{"name":"Institute of Immunology, Philipps-Universit\u00e4t Marburg, Biomedizinisches Forschungszentrum Marburg , Marburg,","place":["Germany"]},{"name":"Institute for Medical Microbiology and Hygiene, Philipps-Universit\u00e4t Marburg , Marburg,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Philipps-Universit\u00e4t Marburg, Biomedizinisches Forschungszentrum Marburg , Marburg,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bucci","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3\u2014Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Grieshaber-Bouyer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3\u2014Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Bauer","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Philipps-Universit\u00e4t Marburg, Biomedizinisches Forschungszentrum Marburg , Marburg,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-8711","authenticated-orcid":false,"given":"Francisco","family":"Venegas-Solis","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Philipps-Universit\u00e4t Marburg, Biomedizinisches Forschungszentrum Marburg , Marburg,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2026020205381078000_keaf537-B1","first-page":"214","author":"Muskardin","year":"2018"},{"key":"2026020205381078000_keaf537-B2","first-page":"87","volume-title":"Current opinion in immunology","author":"Postal","year":"2020"},{"key":"2026020205381078000_keaf537-B3","first-page":"37","author":"Lin","year":"2024"},{"key":"2026020205381078000_keaf537-B4","author":"Thwaites","year":"2014"},{"key":"2026020205381078000_keaf537-B5","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1111\/jcmm.13735","article-title":"The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis","volume":"22","author":"Fischer","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2026020205381078000_keaf537-B6","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.11225","article-title":"Expression of the markers BDCA-2 and BDCA-4 and production of interferon-\u03b1 by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"48","author":"Blomberg","year":"2003","journal-title":"Arthritis Rheum [Internet]"},{"key":"2026020205381078000_keaf537-B7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312404121","article-title":"A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2","volume":"121","author":"Venegas-Solis","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020205381078000_keaf537-B8","doi-asserted-by":"crossref","first-page":"110848","DOI":"10.1016\/j.biopha.2020.110848","article-title":"The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: inhibition of dendritic cell functions via Toll like receptor 9 signaling","volume":"132","author":"Han","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2026020205381078000_keaf537-B9","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2012-01-401364","article-title":"Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37","volume":"120","author":"Chamilos","year":"2012","journal-title":"Blood"},{"key":"2026020205381078000_keaf537-B10","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J Immunol"},{"key":"2026020205381078000_keaf537-B11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2026020205381078000_keaf537-B12","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.173.4.2815","article-title":"Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis","volume":"173","author":"Lande","year":"2004","journal-title":"J Immunol"},{"key":"2026020205381078000_keaf537-B13","doi-asserted-by":"crossref","first-page":"R230","DOI":"10.1186\/ar1467","article-title":"Rheumatoid arthritis synovium contains plasmacytoid dendritic cells","volume":"7","author":"Cavanagh","year":"2005","journal-title":"Arthritis Res Ther [Internet]."},{"key":"2026020205381078000_keaf537-B14","author":"Bruera","year":"2023"},{"key":"2026020205381078000_keaf537-B15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa2118024","article-title":"Trial of anti-BDCA2 antibody litifilimab for cutaneous lupus erythematosus","volume":"387","author":"Werth","year":"2022","journal-title":"New Eng J Med"},{"key":"2026020205381078000_keaf537-B16","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat Commun"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf537\/64717862\/keaf537.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf537\/64717862\/keaf537.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf537\/64717862\/keaf537.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:38:21Z","timestamp":1770028701000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf537\/8287650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf537","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,10,16]]},"article-number":"keaf537"}}